Profiles

Keywords
Last Name
Institution
 Back to Profile

Parameswaran Venugopal

Concepts (221)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Combined Chemotherapy Protocols
18
2021
405
1.900
 Why?
Leukemia, Myeloid, Acute
5
2021
46
1.380
 Why?
Lymphoma, Non-Hodgkin
8
2019
52
1.350
 Why?
Arabinonucleosides
4
2021
7
1.120
 Why?
Lymphoma, Large B-Cell, Diffuse
6
2019
40
1.090
 Why?
Antibodies, Monoclonal
8
2011
301
1.060
 Why?
Antibodies, Monoclonal, Murine-Derived
11
2017
48
0.870
 Why?
Central Nervous System Neoplasms
2
2021
19
0.840
 Why?
Adenine Nucleotides
2
2010
6
0.790
 Why?
Antineoplastic Agents
4
2020
274
0.670
 Why?
Burkitt Lymphoma
3
2021
13
0.640
 Why?
Paraproteinemias
2
2019
5
0.620
 Why?
Lymphoma
1
2017
56
0.620
 Why?
Insulin-Like Growth Factor Binding Proteins
1
2015
15
0.560
 Why?
Insulin-Like Growth Factor I
1
2015
60
0.540
 Why?
Treatment Outcome
18
2021
3910
0.490
 Why?
Adult
21
2021
9779
0.460
 Why?
Cyclophosphamide
9
2021
62
0.440
 Why?
Necrobiotic Xanthogranuloma
1
2011
1
0.440
 Why?
Plasma Cells
1
2011
9
0.440
 Why?
Mediastinum
1
2011
8
0.440
 Why?
Humans
40
2021
31481
0.440
 Why?
Middle Aged
23
2021
11209
0.430
 Why?
Lymphoma, Mantle-Cell
1
2011
12
0.430
 Why?
Aged
20
2021
10295
0.410
 Why?
Male
24
2021
17583
0.400
 Why?
Doxorubicin
7
2021
83
0.390
 Why?
Arsenicals
2
2007
9
0.390
 Why?
Oxides
2
2007
15
0.390
 Why?
Cranial Irradiation
2
2007
18
0.380
 Why?
Vincristine
7
2019
37
0.370
 Why?
Prednisone
7
2019
75
0.360
 Why?
Female
26
2021
18253
0.360
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2008
7
0.350
 Why?
Cachexia
2
2019
15
0.340
 Why?
Disease-Free Survival
7
2021
241
0.330
 Why?
Aged, 80 and over
10
2021
5234
0.330
 Why?
Kaplan-Meier Estimate
5
2021
230
0.330
 Why?
Leukemia, Myelomonocytic, Acute
1
2007
1
0.330
 Why?
Sarcoma, Myeloid
1
2007
4
0.320
 Why?
Ear Neoplasms
1
2007
5
0.320
 Why?
Recurrence
6
2020
389
0.300
 Why?
Purpura, Thrombotic Thrombocytopenic
1
2006
9
0.300
 Why?
Drug Administration Schedule
6
2019
257
0.290
 Why?
Brain Neoplasms
2
2006
187
0.290
 Why?
Combined Modality Therapy
4
2019
456
0.270
 Why?
Immunotherapy
2
2008
74
0.260
 Why?
Lymphomatoid Granulomatosis
1
2003
3
0.260
 Why?
HIV Infections
2
2021
951
0.260
 Why?
Prognosis
6
2021
1028
0.250
 Why?
Lymphoma, B-Cell
3
2008
15
0.250
 Why?
Proto-Oncogene Proteins c-myc
2
2021
26
0.240
 Why?
Remission Induction
6
2015
119
0.220
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
3
2011
30
0.210
 Why?
Drug Resistance, Neoplasm
3
2020
76
0.210
 Why?
Thrombosis
1
2021
67
0.200
 Why?
Benzylidene Compounds
1
2020
2
0.200
 Why?
Azepines
1
2020
6
0.200
 Why?
Multiple Myeloma
1
2020
37
0.190
 Why?
Graft vs Host Disease
1
2020
55
0.190
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2012
18
0.190
 Why?
Folic Acid Deficiency
1
2019
8
0.190
 Why?
Phthalazines
1
2019
9
0.190
 Why?
Respiratory Insufficiency
1
2020
48
0.190
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2019
32
0.180
 Why?
Hematopoietic Stem Cell Transplantation
1
2020
116
0.180
 Why?
Proportional Hazards Models
2
2017
390
0.180
 Why?
Neutropenia
4
2012
26
0.180
 Why?
Cytosine
2
2021
5
0.170
 Why?
Young Adult
4
2021
2277
0.170
 Why?
Piperazines
1
2019
99
0.170
 Why?
Medical Oncology
1
2018
39
0.170
 Why?
Neoplasm Recurrence, Local
3
2021
236
0.170
 Why?
Kidney Diseases
1
2019
146
0.160
 Why?
Immunity
1
2017
23
0.160
 Why?
Cardiology
1
2018
102
0.160
 Why?
Immunocompromised Host
1
2017
55
0.160
 Why?
Stroke Volume
1
2016
64
0.150
 Why?
Biopsy
2
2019
283
0.140
 Why?
Registries
1
2017
214
0.140
 Why?
Feasibility Studies
2
2019
281
0.140
 Why?
Induction Chemotherapy
1
2015
14
0.140
 Why?
Hematologic Neoplasms
1
2014
23
0.130
 Why?
Myelodysplastic Syndromes
2
2004
42
0.130
 Why?
Central Nervous System
2
2021
61
0.130
 Why?
Leukopenia
2
2011
10
0.130
 Why?
Retrospective Studies
3
2019
3591
0.130
 Why?
Lymphoma, Follicular
2
2011
10
0.120
 Why?
Transcription Factors
2
2004
180
0.120
 Why?
Daunorubicin
2
2015
5
0.120
 Why?
Transcriptome
1
2012
87
0.110
 Why?
Hemoglobinuria, Paroxysmal
1
2012
7
0.110
 Why?
DNA-Binding Proteins
2
2004
264
0.110
 Why?
Agranulocytosis
1
2011
7
0.110
 Why?
Yttrium Radioisotopes
1
2011
7
0.110
 Why?
Lymphoma, B-Cell, Marginal Zone
1
2011
7
0.110
 Why?
Diabetes Mellitus, Type 2
1
2014
224
0.110
 Why?
Fatal Outcome
2
2008
75
0.110
 Why?
Obesity
1
2014
338
0.100
 Why?
Retreatment
1
2010
18
0.100
 Why?
Salvage Therapy
1
2010
42
0.100
 Why?
Cytokines
1
2012
364
0.100
 Why?
Platelet Count
2
2007
25
0.100
 Why?
Pilot Projects
1
2011
455
0.090
 Why?
Infusions, Intravenous
2
2020
89
0.080
 Why?
Tretinoin
1
2007
19
0.080
 Why?
Weight Loss
2
2019
114
0.080
 Why?
Injections, Spinal
1
2007
54
0.080
 Why?
Lymphoproliferative Disorders
1
2006
20
0.080
 Why?
Vascular Neoplasms
1
2006
4
0.080
 Why?
Tomography, X-Ray Computed
1
2011
891
0.080
 Why?
Plasma Exchange
1
2006
20
0.070
 Why?
Follow-Up Studies
1
2011
2028
0.070
 Why?
ADAM Proteins
1
2006
95
0.070
 Why?
Hemoglobins
1
2006
81
0.070
 Why?
Twins, Dizygotic
1
2005
4
0.070
 Why?
Autoantibodies
1
2006
119
0.070
 Why?
Severity of Illness Index
2
2021
1240
0.070
 Why?
Survival Analysis
2
2019
379
0.070
 Why?
Proto-Oncogenes
1
2004
5
0.070
 Why?
Thalidomide
1
2004
9
0.070
 Why?
Radiography
1
2007
717
0.070
 Why?
Kidney Transplantation
1
2006
141
0.070
 Why?
Etoposide
2
2019
64
0.070
 Why?
Peripheral Blood Stem Cell Transplantation
1
2004
7
0.070
 Why?
Cohort Studies
2
2021
2014
0.070
 Why?
Antigens, CD20
1
2003
8
0.060
 Why?
Epilepsy, Tonic-Clonic
1
2003
9
0.060
 Why?
Herpesvirus 4, Human
1
2003
17
0.060
 Why?
Vision Disorders
1
2003
26
0.060
 Why?
Epstein-Barr Virus Infections
1
2003
19
0.060
 Why?
Cyclin D1
1
2003
5
0.060
 Why?
United States
2
2021
2539
0.060
 Why?
Antigens, Neoplasm
1
2003
53
0.060
 Why?
Cell Cycle Proteins
1
2003
15
0.060
 Why?
K562 Cells
1
2003
7
0.060
 Why?
Telomerase
1
2003
11
0.060
 Why?
Methotrexate
1
2003
47
0.060
 Why?
Histones
1
2003
32
0.060
 Why?
Cytarabine
2
2015
12
0.060
 Why?
Apoptosis
1
2003
292
0.050
 Why?
Cerebral Cortex
1
2003
206
0.050
 Why?
Azacitidine
1
2021
14
0.050
 Why?
L-Lactate Dehydrogenase
1
2021
9
0.050
 Why?
Gene Rearrangement
1
2021
16
0.050
 Why?
Risk Factors
2
2005
2664
0.050
 Why?
Thrombocytopenia
2
2012
32
0.050
 Why?
Folic Acid
1
2019
24
0.050
 Why?
Monoclonal Gammopathy of Undetermined Significance
1
2019
2
0.050
 Why?
Maintenance Chemotherapy
1
2019
4
0.050
 Why?
Kidney Function Tests
1
2019
29
0.050
 Why?
Immunoglobulin A
1
2019
18
0.050
 Why?
Maximum Tolerated Dose
1
2019
20
0.050
 Why?
Translocation, Genetic
1
2019
13
0.050
 Why?
Symptom Assessment
1
2019
24
0.050
 Why?
Anemia
2
2012
94
0.050
 Why?
Vidarabine
2
2011
11
0.050
 Why?
Transplantation, Homologous
1
2020
292
0.040
 Why?
Postoperative Complications
1
2006
1083
0.040
 Why?
Sarcopenia
1
2019
34
0.040
 Why?
Body Composition
1
2019
81
0.040
 Why?
Mitoxantrone
2
2011
6
0.040
 Why?
Interdisciplinary Communication
1
2018
31
0.040
 Why?
Ovarian Neoplasms
1
2019
82
0.040
 Why?
Magnetic Resonance Imaging
1
2003
1273
0.040
 Why?
Disease Management
1
2019
147
0.040
 Why?
Lung Neoplasms
1
2003
756
0.040
 Why?
Sex Factors
1
2019
542
0.040
 Why?
Tomography, Emission-Computed
2
2006
13
0.040
 Why?
Prospective Studies
2
2015
1934
0.040
 Why?
Neoplasms
1
2019
280
0.040
 Why?
Recombinant Proteins
2
2008
295
0.040
 Why?
Disease Progression
2
2012
861
0.040
 Why?
Naphthalimides
1
2015
2
0.040
 Why?
Adenine
1
2015
7
0.040
 Why?
Organophosphonates
1
2015
6
0.040
 Why?
Lipid Metabolism
1
2014
50
0.030
 Why?
Sensitivity and Specificity
2
2006
580
0.030
 Why?
Adolescent
1
2021
2667
0.030
 Why?
Insulin Resistance
1
2014
71
0.030
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2004
191
0.030
 Why?
Cytogenetic Analysis
1
2012
7
0.030
 Why?
Administration, Oral
1
2012
164
0.030
 Why?
RNA, Messenger
2
2003
371
0.030
 Why?
Pneumonia
1
2012
74
0.030
 Why?
Signal Transduction
1
2014
588
0.030
 Why?
Radiopharmaceuticals
1
2011
63
0.030
 Why?
Time Factors
1
2015
1902
0.020
 Why?
Nausea
1
2007
25
0.020
 Why?
Methylprednisolone
1
2007
26
0.020
 Why?
Creatinine
1
2007
59
0.020
 Why?
Cisplatin
1
2007
107
0.020
 Why?
Dose-Response Relationship, Drug
1
2006
512
0.020
 Why?
Zinc Fingers
1
2004
10
0.020
 Why?
Animals
1
2014
5312
0.020
 Why?
Cell Lineage
1
2004
34
0.020
 Why?
Spleen
1
2004
54
0.020
 Why?
Teniposide
1
2004
2
0.020
 Why?
Bleomycin
1
2004
4
0.020
 Why?
E2F1 Transcription Factor
1
2003
3
0.020
 Why?
S Phase
1
2003
12
0.020
 Why?
E2F Transcription Factors
1
2003
5
0.020
 Why?
Retinoblastoma Protein
1
2003
7
0.020
 Why?
Drug Therapy, Combination
1
2004
265
0.020
 Why?
Interferon-alpha
1
2004
71
0.020
 Why?
Karyotyping
1
2003
14
0.020
 Why?
Neoplasm Staging
1
2005
481
0.020
 Why?
Transplantation, Autologous
1
2004
223
0.020
 Why?
DNA Primers
1
2003
64
0.020
 Why?
Granulocytes
1
2003
25
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2003
42
0.020
 Why?
Patient Selection
1
2005
264
0.020
 Why?
Bone Marrow Cells
1
2003
63
0.020
 Why?
Cell Nucleus
1
2003
90
0.020
 Why?
Transcription, Genetic
1
2003
125
0.020
 Why?
Immunosuppressive Agents
1
2004
163
0.020
 Why?
Blotting, Western
1
2003
225
0.010
 Why?
Bone Marrow
1
2003
68
0.010
 Why?
Polymerase Chain Reaction
1
2003
188
0.010
 Why?
Acute Disease
1
2003
254
0.010
 Why?
Immunohistochemistry
1
2003
494
0.010
 Why?
Venugopal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (221) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department